Pharma Foods International Co., Ltd., 56% Decrease in Ordinary Profit for The Current Fiscal Year

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Sep 12, 2024 3:00 pm JST Earnings

2929 Pharma Foods International Co., Ltd. 【J-GAAP】

Earnings Report

Pharma Foods International Co., Ltd. <2929> [TSE-P] announced its financial results after the market closed on September 12th (15:00). The consolidated ordinary profit for the fiscal year ending July 2024 expanded to 48.3% from the previous period to 5.24 billion yen. However, for the fiscal year ending July 2025 is also bleak, with an expected significant drop by 56.2% from the previous period to 2.3 billion yen.

In the most recent three-month period, from May to July (4Q), the consolidated ordinary profit grew by 3.5% from the same period last year, reaching 2.02 billion yen. The operating profit margin remained almost flat, changing from 12.3% in the same period last year to 12.3%.

Kabutan News

Actual Results

Historical Performance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul, 2022	60,185	1,080	1,264	-374	-12.9	20	Sep 6, 2022	J-GAAP
Jul, 2023	68,572	3,610	3,540	3,081	106.7	22	Sep 11, 2023	J-GAAP
Jul, 2024	62,147	5,113	5,249	3,205	112.7	25	Sep 12, 2024	J-GAAP
YoY	-9.4%	+41.6%	+48.3%	+4.0%	+5.6%

Full Year Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul, 2024 Guidance	62,000	5,000	5,100	3,500	124.7	25	Jul 25, 2024	J-GAAP
Jul, 2024 Results	62,147	5,113	5,249	3,205	112.7	25	Sep 12, 2024	J-GAAP
Revision Rate	+0.2%	+2.3%	+2.9%	-8.4%	-9.6%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Aug - Jan, 2023	31,652	1,535	1,542	768	26.7	10	Mar 11, 2024	J-GAAP
Aug - Jan, 2024 Guidance	ー	ー	ー	ー	－	12.50	Sep 12, 2024	J-GAAP
YoY	－	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul, 2023	68,572	3,610	3,540	3,081	106.7	22	Sep 11, 2023	J-GAAP
Jul, 2024	62,147	5,113	5,249	3,205	112.7	25	Sep 12, 2024	J-GAAP
Jul, 2025 Guidance	65,000	2,000	2,300	1,600	55.1	25	Sep 12, 2024	J-GAAP
YoY	+4.6%	-60.9%	-56.2%	-50.1%	-51.1%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
May - Jul, 2023	16,039	1,976	1,958	2,013	69.7	12.3	Sep 11, 2023	J-GAAP
Aug - Oct, 2023	16,142	601	605	286	9.9	3.7	Dec 11, 2023	J-GAAP
Nov - Jan, 2023	15,510	934	937	482	16.7	6.0	Mar 11, 2024	J-GAAP
Feb - Apr, 2024	15,519	1,731	1,681	1,088	38.1	11.2	Jun 10, 2024	J-GAAP
May - Jul, 2024	14,976	1,847	2,026	1,349	47.4	12.3	Sep 12, 2024	J-GAAP
YoY	-6.6%	-6.5%	+3.5%	-33.0%	-31.9%